hers glp 1 microdosing Microdose GLP-1 Protocol Hims & Hers stock crashes

In the second trial, SURPASS-2, tirzepatide administered at doses of 5 mg, 10 mg, or 15 mg showed superior efficacy compared to semaglutide (1 mg) in reducing body weight and HbA1c levels over 40 weeks in patients with T2DM inadequately controlled with metformin [66]

23% of Americans and 16% of Britons reported no concerns about stopping GLP-1s

A 2025 scoping review by McGuire and colleagues (Curr Rev Musculoskelet Med) found no adequately powered randomised controlled trials for BPC-157 in musculoskeletal healing

This has important implications for the many cancers that are linked to the development of metabolic syndrome in ageing adults such as tumours of the breast and prostate

Think of it as giving your body the best possible conditions to repair while BPC-157 removes the bottlenecks

Husk ogs at lojalitetsprogrammer og faste kampanjer ofte kan vre mer verdifulle over tid enn ett enkelt, stort velkomsttilbud